Menu Back toTOPIC-2-SESSION-8-CONTINUED-Audits-and-Inspections-in-Pharmacovigilance

Joint MHRA/DIA Excellence in Pharmacovigilance

This course is designed to provide a firm grounding in key aspects of European Clinical Pre- and Post-Marketing Safety regulatory requirements.


TOPIC 2 SESSION 8 CONTINUED: Audits and Inspections in Pharmacovigilance

Session Chair(s)

Gaby L. Danan, MD, PhD

Gaby L. Danan, MD, PhD

  • Pharmacovigilance Expert
  • GLD, France
Phil  Tregunno

Phil Tregunno

  • Group Manager, Vigilance, Intelligence and Research Group
  • Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Speaker(s)

Jonathan  Rowell

Audits and Inspections in Pharmacovigilance - Industry Perspective

Jonathan Rowell

  • Director Regulatory Compliance
  • Janssen Pharmaceutical Research & Development Quality & Compliance, United Kingdom

Contact us


Registration Questions

Send Email
+41 61 225 51 51



Agenda and Logistics

Send Email
+41 61 225 51 55